纳指生物科技ETF(513290)
动态评分： 5.70分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | SLN | Silence Therapeutics plc ADR | 49.27 | 0.03% |
| 2024-12-31 | OLMA | Olema Pharmaceuticals Inc | 50.91 | 0.03% |
| 2024-12-31 | NGNE | Neurogene Inc | 51.76 | 0.03% |
| 2024-12-31 | AVIR | Atea Pharmaceuticals Inc | 43.13 | 0.03% |
| 2024-12-31 | PGEN | Precigen Inc | 50 | 0.03% |
| 2024-12-31 | TNGX | Tango Therapeutics Inc | 50.59 | 0.03% |
| 2024-12-31 | FHTX | Foghorn Therapeutics Inc | 40 | 0.03% |
| 2024-12-31 | AMLX | Amylyx Pharmaceuticals Inc | 39.49 | 0.03% |
| 2024-12-31 | DSGN | Design Therapeutics Inc | 53.25 | 0.03% |
| 2024-12-31 | CRVS | Corvus Pharmaceuticals Inc | 52.4 | 0.03% |
| 2024-12-31 | TRVI | Trevi Therapeutics Inc | 48.27 | 0.03% |
| 2024-12-31 | RVNC | Revance Therapeutics Inc | 48.61 | 0.03% |
| 2024-12-31 | AQST | Aquestive Therapeutics Inc | 49.47 | 0.03% |
| 2024-12-31 | SLRN | ACELYRIN INC | 48.02 | 0.03% |
| 2024-12-31 | LXRX | 莱斯康制药 | 40.69 | 0.03% |
| 2024-12-31 | CCCC | C4 Therapeutics Inc | 38.73 | 0.03% |
| 2024-12-31 | RIGL | Rigel Pharmaceuticals Inc | 45.16 | 0.03% |
| 2024-12-31 | ACIU | AC Immune SA | 40.7 | 0.03% |
| 2024-12-31 | SAGE | Sage Therapeutics Inc | 50.63 | 0.03% |
| 2024-12-31 | VYGR | Voyager Therapeutics Inc | 47.21 | 0.03% |
公告&资料
